NRMX

Neurochem (NRMX)

Neurochem - Common Shares (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NRMX

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2008/04/17	00:57	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/04/15	21:00	PR Newswire (US)	At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update o	NASDAQ:NRMX
2008/04/12	05:27	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/04/12	03:30	PR Newswire (US)	Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008	NASDAQ:NRMX
2008/04/12	01:24	PR Newswire (US)	Neurochem Annual and Special Meeting of shareholders	NASDAQ:NRMX
2008/04/11	00:26	Edgar (US Regulatory)	Neurochem Inc - Amended Annual Report (foreign private issuer) (40-F/A)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/03/21	01:48	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/03/15	06:23	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/03/15	06:07	Edgar (US Regulatory)	Neurochem Inc - Annual Report (foreign private issuer) (40-F)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/03/14	04:25	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/03/13	20:00	PR Newswire (US)	Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis	NASDAQ:NRMX
2008/02/23	04:10	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/02/22	09:19	PR Newswire (US)	Neurochem announces departure of two members of management team	NASDAQ:NRMX
2008/02/22	06:54	Edgar (US Regulatory)	Neurochem Inc - Amended Report of Foreign Issuer (6-K/A)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/02/22	05:18	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/02/21	09:12	PR Newswire (US)	Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives	NASDAQ:NRMX
2008/02/16	05:45	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/02/14	02:26	PR Newswire (US)	/C O R R E C T I O N from source -- Neurochem Inc./	NASDAQ:NRMX
2008/02/12	05:55	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/02/12	00:46	PR Newswire (US)	Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live	NASDAQ:NRMX
2008/01/31	06:26	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/01/30	22:00	PR Newswire (US)	Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business	NASDAQ:NRMX
2008/01/04	05:59	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2008/01/04	03:08	PR Newswire (US)	Neurochem to present at JPMorgan Healthcare Conference	NASDAQ:NRMX
2007/12/15	05:51	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2007/12/14	22:24	PR Newswire (US)	Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis	NASDAQ:NRMX
2007/12/08	07:25	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2007/12/07	07:09	PR Newswire (US)	Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review	NASDAQ:NRMX
2007/12/04	05:05	Edgar (US Regulatory)	Neurochem Inc - Report of Foreign Issuer (6-K)	NASDAQ:NRMX	Neurochem - Common Shares (MM)
2007/12/01	06:15	PR Newswire (US)	Neurochem announces departure of Dr. Philippe Calais, President, Global Business	NASDAQ:NRMX